Ticker name:MIRAMIRA PHARMACEUTICALS, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.

Market Cap 32M

Last close 0.759$

Key metrics

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.1T1152.44$
2JNJJOHNSON & JOHNSON651B270.22$
3ABBVAbbVie Inc.467B264.02$
4MRKMerck & Co., Inc.363B147.15$
5NVSNOVARTIS AG269B140.92$
6AZNASTRAZENECA PLC258B166.14$
7AMGNAMGEN INC205B379.78$
8GILDGILEAD SCIENCES, INC.187B150.89$
9PFEPFIZER INC158B27.64$
10BMYBRISTOL MYERS SQUIBB CO128B62.84$
11SNYSanofi105B43.14$
12BIIBBIOGEN INC.32B219.05$
13ZTSZoetis Inc.30B73.02$
14OGNOrganon & Co.3.6B13.69$
15CTORCITIUS ONCOLOGY, INC.95M1.02$
16SCLXScilex Holding Co46M5.37$
17SRXHSRX Global Inc.33M1.62$
18MIRAMIRA PHARMACEUTICALS, INC.32M0.7593$